Shen S - Search Results

1

Ferroptosis, as the most enriched programmed cell death process in glioma, induces immunosuppression and immunotherapy resistance.

Liu T, Zhu C, Chen X, Guan G, Zou C, Shen S, Wu J, Wang Y, Lin Z, Chen L, Cheng P, Cheng W, Wu A. Liu T, et al. Among authors: shen s. Neuro Oncol. 2022 Jul 1;24(7):1113-1125. doi: 10.1093/neuonc/noac033. Neuro Oncol. 2022. PMID: 35148413 Free PMC article.

2

CD48 is a key molecule of immunomodulation affecting prognosis in glioma.

Zou C, Zhu C, Guan G, Guo Q, Liu T, Shen S, Yan Z, Xu X, Lin Z, Chen L, Wu A, Cheng W. Zou C, et al. Among authors: shen s. Onco Targets Ther. 2019 May 28;12:4181-4193. doi: 10.2147/OTT.S198762. eCollection 2019. Onco Targets Ther. 2019. PMID: 31213836 Free PMC article.

3

Development and validation of an interferon signature predicting prognosis and treatment response for glioblastoma.

Zhu C, Zou C, Guan G, Guo Q, Yan Z, Liu T, Shen S, Xu X, Chen C, Lin Z, Cheng W, Wu A. Zhu C, et al. Among authors: shen s. Oncoimmunology. 2019 Jun 12;8(9):e1621677. doi: 10.1080/2162402X.2019.1621677. eCollection 2019. Oncoimmunology. 2019. PMID: 31428519 Free PMC article.

4

Evaluation of a tumor electric field treatment system in a rat model of glioma.

Wu H, Wang C, Liu J, Zhou D, Chen D, Liu Z, Wu A, Yang L, Chang J, Luo C, Cheng W, Shen S, Bai Y, Mu X, Li C, Wang Z, Chen L. Wu H, et al. Among authors: shen s. CNS Neurosci Ther. 2020 Nov;26(11):1168-1177. doi: 10.1111/cns.13441. Epub 2020 Jul 30. CNS Neurosci Ther. 2020. PMID: 32734621 Free PMC article.

5

Characterization of ROS Metabolic Equilibrium Reclassifies Pan-Cancer Samples and Guides Pathway Targeting Therapy.

Shen S, Yan Z, Wu J, Liu X, Guan G, Zou C, Guo Q, Zhu C, Liu T, Chen C, Chen L, Cheng P, Cheng W, Wu A. Shen S, et al. Front Oncol. 2020 Oct 20;10:581197. doi: 10.3389/fonc.2020.581197. eCollection 2020. Front Oncol. 2020. PMID: 33194713 Free PMC article.

6

Genome profiling of mismatch repair genes in eight types of tumors.

Wang S, Guan G, Zou C, Guo Q, Cheng W, Shen S, Dong F, Wu A, Li G, Zhu C. Wang S, et al. Among authors: shen s. Cell Cycle. 2021 Jun;20(11):1091-1106. doi: 10.1080/15384101.2021.1922160. Epub 2021 May 9. Cell Cycle. 2021. PMID: 33966609 Free PMC article.

7

Establishment of tumor inflammasome clusters with distinct immunogenomic landscape aids immunotherapy.

Liang Q, Wu J, Zhao X, Shen S, Zhu C, Liu T, Cui X, Chen L, Wei C, Cheng P, Cheng W, Wu A. Liang Q, et al. Among authors: shen s. Theranostics. 2021 Oct 17;11(20):9884-9903. doi: 10.7150/thno.63202. eCollection 2021. Theranostics. 2021. PMID: 34815793 Free PMC article.

8

The Systematic Landscape of Nectin Family and Nectin-Like Molecules: Functions and Prognostic Value in Low Grade Glioma.

Han Y, Zou C, Zhu C, Liu T, Shen S, Cheng P, Cheng W, Wu A. Han Y, et al. Among authors: shen s. Front Genet. 2021 Dec 1;12:718717. doi: 10.3389/fgene.2021.718717. eCollection 2021. Front Genet. 2021. PMID: 34925438 Free PMC article.

9

Development of a T-cell activation-related module with predictive value for the prognosis and immune checkpoint blockade therapy response in glioblastoma.

Yan Z, Chu S, Zhu C, Han Y, Liang Q, Shen S, Cheng W, Wu A. Yan Z, et al. Among authors: shen s. PeerJ. 2021 Dec 22;9:e12547. doi: 10.7717/peerj.12547. eCollection 2021. PeerJ. 2021. PMID: 35036121 Free PMC article.

10

Dual role of ARPC1B in regulating the network between tumor-associated macrophages and tumor cells in glioblastoma.

Liu T, Zhu C, Chen X, Wu J, Guan G, Zou C, Shen S, Chen L, Cheng P, Cheng W, Wu A. Liu T, et al. Among authors: shen s. Oncoimmunology. 2022 Jan 27;11(1):2031499. doi: 10.1080/2162402X.2022.2031499. eCollection 2022. Oncoimmunology. 2022. PMID: 35111386 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

8,149 results

Search Page